A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site, Budapest

GSK Investigational Site, Hakadal

GSK Investigational Site, Løvenstad

GSK Investigational Site, Törökbálint

GSK Investigational Site, Hamar

GSK Investigational Site, Balassagyarmat

GSK Investigational Site, Concepción del Uruguay

GSK Investigational Site, San Miguel de Tucumán

GSK Investigational Site, Debrecen

GSK Investigational Site, Debrecen

GSK Investigational Site, Kolbjørnsvik

GSK Investigational Site, Mendoza

GSK Investigational Site, San Rafael

GSK Investigational Site, Ålesund

GSK Investigational Site, Nagykanizsa

GSK Investigational Site, Kapuvár

GSK Investigational Site, Peralada( Girona)

GSK Investigational Site, Lübeck

GSK Investigational Site, Brinkum/Stuhr

GSK Investigational Site, Fuenlabrada / Madrid

GSK Investigational Site, Hanover

GSK Investigational Site, Hanover

GSK Investigational Site, Laredo

GSK Investigational Site, Essen

GSK Investigational Site, Gelsenkirchen

GSK Investigational Site, Düren

GSK Investigational Site, Koblenz

GSK Investigational Site, Frankfurt am Main

GSK Investigational Site, Ostrava - Poruba

GSK Investigational Site, Munich

GSK Investigational Site, Bamberg

GSK Investigational Site, Moscow

GSK Investigational Site, Moscow

GSK Investigational Site, Ivanovo

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petesburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Râmnicu Vâlcea

GSK Investigational Site, Timișoara

GSK Investigational Site, Stavropol

GSK Investigational Site, Ryazan

GSK Investigational Site, Cluj-Napoca

GSK Investigational Site, Kazan'

GSK Investigational Site, Chelyabinsk

GSK Investigational Site, Chelyabinsk

GSK Investigational Site, Chelyabinsk

GSK Investigational Site, Brasov

GSK Investigational Site, Nizhny Novgorod

GSK Investigational Site, Perm

GSK Investigational Site, Yekaterinburg

GSK Investigational Site, Kemerovo

GSK Investigational Site, Barnaul

GSK Investigational Site, Barnaul

GSK Investigational Site, Irkutsk

GSK Investigational Site, Chita

GSK Investigational Site, Iași

GSK Investigational Site, Suceava

GSK Investigational Site, Talca

GSK Investigational Site, Concepción

GSK Investigational Site, Santiago

GSK Investigational Site, Santiago

GSK Investigational Site, Santiago

GSK Investigational Site, Puente Alto - Santiago

GSK Investigational Site, Santiago

GSK Investigational Site, Santiago

GSK Investigational Site, Paraná

GSK Investigational Site, Rosario

GSK Investigational Site, Mendoza

GSK Investigational Site, San Miguel de Tucumán

GSK Investigational Site, Jindřichův Hradec

GSK Investigational Site, Kralupy nad Vltavou

GSK Investigational Site, Lovosice

GSK Investigational Site, Rudna U Prahy

GSK Investigational Site, Třebíč

GSK Investigational Site, Varnsdorf

GSK Investigational Site, Leipzig

GSK Investigational Site, Leipzig

GSK Investigational Site, Leipzig

GSK Investigational Site, Hønefoss

GSK Investigational Site, Kongsvinger

GSK Investigational Site, Bucharest

GSK Investigational Site, Moscow

GSK Investigational Site, Novosibirsk

GSK Investigational Site, Barcelona

GSK Investigational Site, Barcelona

GSK Investigational Site, Barcelona

GSK Investigational Site, La Roca Del Valles (Barcelona)

GSK Investigational Site, Gothenburg

GSK Investigational Site, Gothenburg

GSK Investigational Site, Stockholm

GSK Investigational Site, Stockholm